SCHEDULE: MetLife Board Reports 16.17% Stake via Policyholder Trust

MetLife's Board of Directors has reported beneficial ownership of 106.5 million common shares, representing 16.17% of the company's outstanding stock, held through the MetLife Policyholder Trust.

Summary

• The Board of Directors of MetLife, Inc. beneficially owns 106,549,803 shares of Common Stock, representing 16.17% of the Issuer's outstanding Common Stock.
• These shares are held by the MetLife Policyholder Trust (the "Trust"), established under the Plan of Reorganization dated September 28, 1999, as amended.
• The Trust initially received 494,466,664 shares on April 7, 2000, for the benefit of eligible policyholders of Metropolitan Life Insurance Company ("MetLife").
• Since April 7, 2000, the number of shares held by the Trust has decreased due to beneficiary transactions, the split-off of Reinsurance Group of America, Incorporated in 2008, withdrawals, and escheatment of unclaimed shares.
• The Trust's holdings decreased from 108,242,821 shares to 106,549,803 shares since July 31, 2025.
• The Board directs the voting of these shares on most matters, voting in accordance with its recommendations to stockholders.
• For specific "Beneficiary Consent Matters" (e.g., contested director elections, mergers, major asset sales), the Trustee votes shares in the same ratio as instructions received from beneficiaries.
• Beneficiaries have the right to receive dividends and proceeds from the sale of their allocated shares and can withdraw shares from the Trust.

Sentiment

Score: 5

Explanation: The filing is a routine amendment to a Schedule 13D, providing an update on beneficial ownership through a long-standing trust structure. It contains factual information without indicating positive or negative operational performance or strategic shifts.

Positives

• The established MetLife Policyholder Trust structure provides a clear framework for managing a significant block of shares, contributing to governance stability.
• Beneficiaries retain rights to dividends and proceeds from the sale of their allocated shares, ensuring their financial interests are maintained.

Negatives

• The number of shares held by the MetLife Policyholder Trust has continued to decrease, falling from 108,242,821 to 106,549,803 shares since July 31, 2025, indicating ongoing withdrawals by beneficiaries.

Risks

• The ongoing ability of beneficiaries to withdraw shares from the Trust means the aggregate amount of shares beneficially owned by the Board through the Trust will continue to decrease over time, potentially reducing the Board's voting influence on certain matters.

Future Outlook

The filing does not provide a future outlook for MetLife's business operations or financial performance. It primarily details the ongoing beneficial ownership structure of the MetLife Policyholder Trust and the mechanisms for share voting and withdrawal.

Management Comments

• The Board of Directors, as an entity, is reporting beneficial ownership of shares held by the MetLife Policyholder Trust, reflecting its oversight role in the trust's voting mechanisms.

Industry Context

This filing pertains to a legacy ownership structure stemming from MetLife's demutualization, a process common among insurance companies transitioning from mutual to stock ownership. The MetLife Policyholder Trust is a specific mechanism to manage the interests of former policyholders, a unique aspect of the insurance industry's corporate evolution.

Comparison to Industry Standards

• Not directly comparable to industry standards for operational performance or financial results, as this filing details a specific, legacy policyholder trust structure resulting from MetLife's demutualization.
• The structure of a policyholder trust with specific voting rights and withdrawal provisions is a unique feature for demutualized insurers like MetLife, rather than a standard corporate governance model across all public companies.

Corporate Governance

Related Party Transactions

• The MetLife Policyholder Trust holds shares for the benefit of eligible policyholders of MetLife, who are key stakeholders. The Trust Agreement outlines the rights of these beneficiaries to receive dividends and proceeds from share sales.

Stakeholder Impact

• Shareholders: The significant block of shares (16.17%) held by the Trust, with its specific voting rules, impacts the overall voting dynamics and corporate governance of MetLife.
• Policyholders (Beneficiaries): These individuals continue to benefit from their allocated Trust Interests, including the right to receive dividends and proceeds from share sales, and direct voting on certain key corporate matters.

Next Steps

• Beneficiaries of the MetLife Policyholder Trust may continue to withdraw their allocated shares, which will further reduce the total shares held by the Trust.
• The Board of Directors will continue to direct the voting of the Trust's shares on most matters, while beneficiaries will direct voting on specific "Beneficiary Consent Matters."

Key Dates

Keywords

MetLife, common stock, Schedule 13D, beneficial ownership, policyholder trust, corporate governance, voting rights, demutualization, shareholder rights